Cargando…
From ARDS to pulmonary fibrosis: the next phase of the COVID-19 pandemic?
While the coronavirus disease 19 (COVID-19) pandemic has transformed the medical and scientific communites since it was first reported in late 2019, we are only beginning to understand the chronic health burdens associated with this disease. Although COVID-19 is a multi-systemic disease, the lungs a...
Autores principales: | Michalski, Jacob E., Kurche, Jonathan S., Schwartz, David A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8452088/ https://www.ncbi.nlm.nih.gov/pubmed/34547499 http://dx.doi.org/10.1016/j.trsl.2021.09.001 |
Ejemplares similares
-
Dysregulated Cell–Cell Communication Characterizes Pulmonary Fibrosis
por: Kurche, Jonathan S., et al.
Publicado: (2022) -
Stem cell therapy for COVID‐19, ARDS and pulmonary fibrosis
por: Li, Zhongwen, et al.
Publicado: (2020) -
Genetic Risk Factors for Idiopathic Pulmonary Fibrosis: Insights into Immunopathogenesis
por: Michalski, Jacob E, et al.
Publicado: (2021) -
Spatially distinct molecular patterns of gene expression in idiopathic pulmonary fibrosis
por: Blumhagen, Rachel Z., et al.
Publicado: (2023) -
Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target
por: Ntatsoulis, Konstantinos, et al.
Publicado: (2021)